MeSH D064420 - drug-related side effects and adverse reactions
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D064419:Chemically-induced disorders
0 Companies
0 Drugs
Success rate
D000072736:Propofol infusion syndrome
0 Companies
0 Drugs
Success rate
D000075662:Injection site reaction
0 Companies
0 Drugs
Success rate
D000081015:Ototoxicity
D000081028:Toxic optic neuropathy
0 Companies
0 Drugs
Success rate
D000081030:Myotoxicity
0 Companies
0 Drugs
Success rate
D000084202:Chemotherapy-related cognitive impairment
0 Companies
0 Drugs
Success rate
D004409:Drug-induced dyskinesia
D017109:Drug-induced akathisia
D020230:Serotonin syndrome
0 Companies
0 Drugs
Success rate
D056486:Chemical and drug induced liver injury
0 Companies
0 Drugs
Success rate
D064807:Anticholinergic syndrome
0 Companies
0 Drugs
Success rate
D066126:Cardiotoxicity
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
62%18/29
Phase 2
37%19/52
Phase 3
27%17/63
Approved: 1Overall Success rate: 6%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use